|
1.4 Biologie - Technos
|
|
|
|
Gene editing tool may raise cancer risk in cells, scientists warn [Reuters]
|
|
|
|
|
|
“Although
we don’t yet understand the mechanisms ... we believe that researchers
need to be aware of the potential risks when developing new treatments,”
Taipale said in a statement as the work was published. “This is why we
decided to publish our findings as soon as we discovered that cells
edited with CRISPR-Cas9 can go on to become cancerous.”
|
|
|
|
|
|
|
|
4.1 Dép., diag. & prono. - Prostate
|
|
|
|
|
|
|
4.12 Biopsies liquides
|
|
|
|
4.2 Dép., diag. & prono. - Génome
|
|
|
|
5.1 Traitements - Pré-clinique
|
|
|
|
5.12 Immunothérapies
|
|
|
|
5.12.7 Immunothérapies - vaccins
|
|
|
|
5.2 Pharma
|
|
|
|
5.2.3 Pharma - économie
|
|
|
|
5.3.4 Traitements - AMM (FDA, EMA,...)
|
|
|
|
|
5.4 Traitements - Economie
|
|
|
Easier Drug Approval Isn’t Cutting Drug Prices [NY Times]
|
|
|
|
|
|
Based
on the data we do have, the thousand-plus cancer drugs now in clinical
development are quite likely to help only a handful of patients, and
only a very little bit: According to one recent study, targeted cancer
therapies will benefit fewer than 2 percent of the cancer patients
they’re aimed at.
|
|
|
|
|
|
|
5.5 ASCO
|
|
|
Maximizing the Prospects for Progress Against Cancer [NCI]
|
|
|
|
|
|
Since
the beginning of my training as an oncologist in 1996, I have often
attended the American Society of Clinical Oncology (ASCO) annual
meeting. This year’s meeting, however, was the first where I had the
honor of attending and speaking in my role as NCI director.
|
|
|
|
|
|
|
Sharpless: NCI adds $10 million for NCTN and NCORP trials [The Cancer Letter]
|
|
|
|
|
|
NCI’s
major efforts with regards to large clinical trials are largely
supported through our clinical trials networks like the National
Clinical Trials Network,” Sharpless said in his June 2 talk at ASCO.
“One of the major challenges for these networks over the past few years,
however, has been a rapid increase in the per-patient costs for
patients on trials.
|
|
|
|
|
|
|
5.5.16.2 ASCO (médecine de précision-sein)
|
|
|
|
6. Lutte contre les cancers
|
|
|
|
6.6 Publications
|
|
|
|